Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025 2026
Market Cap 1 91.84 79.88
Change - -13.02%
Enterprise Value (EV) 1 61.1 64.14
Change - 4.98%
P/E 21.2x 19.1x
PBR 1.04x 0.86x
PEG -1.1x -5.48x
Capitalization / Revenue 1.12x 0.84x
EV / Revenue 0.74x 0.68x
EV / EBITDA 7.34x 6.31x
EV / EBIT 16x 12.6x
EV / FCF - -
FCF Yield - -
Dividend per Share 2 - -
Rate of return - -
EPS 2 1.896 1.83
Distribution rate - -
Net sales 1 82.35 94.91
EBITDA 1 8.319 10.16
EBIT 1 3.821 5.079
Net income 1 3.947 4.179
Net Debt 1 -30.75 -15.75
Reference price 2 40.24 35.00
Nbr of stocks (in thousands) 2,282 2,282
Announcement Date 25/08/25 21/08/26
1INR in Million2INR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 806K
11.53x0.37x7.59x3.28% 103B
15.72x1.9x9.47x0.65% 99.34B
-172.76x12.8x-195.96x-.--% 39.64B
16.05x1.66x10.02x2.31% 31.77B
27.02x2.36x13.39x0.79% 29.81B
25.02x2.76x14.03x1.28% 28.42B
7.24x1.43x6.24x-.--% 20.95B
28.68x5.14x21.05x2.44% 19.39B
30.57x2.87x12.92x1.45% 16.97B
Average -1.22x 3.48x -11.25x 1.36% 39B
Weighted average by Cap. -2.16x 2.86x -10.70x 1.56%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Clinitech Laboratory Limited

Historical PBR trend

Valuation ratios - PBR - Clinitech Laboratory Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Clinitech Laboratory Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Clinitech Laboratory Limited

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited